LEADER 01109nam  2200385   450 
001 9910583098103321
005 20180322211406.0
010   $a0-08-101118-0
035   $a(CKB)3710000001150941
035   $a(MiAaPQ)EBC4837616
035   $a(PPN)220151393
035   $a(EXLCZ)993710000001150941
100   $a20170425h20172017  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aDesign of hybrid molecules for drug development /$fedited by Michael Decker
210  1$aLondon, [England] :$cElsevier,$d2017.
210  4$dİ2017
215   $a1 online resource (354 pages) $cillustrations, tables
311   $a0-08-101011-7 
320   $aIncludes bibliographical references and index.
606   $aDrugs$xDesign
615  0$aDrugs$xDesign.
676   $a615.19
702   $aDecker$b Michael
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910583098103321
996   $aDesign of hybrid molecules for drug development$91922041
997   $aUNINA